These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 19241252)

  • 1. Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design.
    Demberg T; Robert-Guroff M
    Int Rev Immunol; 2009; 28(1):20-48. PubMed ID: 19241252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal Vaccination for Prevention of HIV Infection and AIDS.
    Aldovini A
    Curr HIV Res; 2016; 14(3):247-59. PubMed ID: 26957199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responses.
    Vargas-Inchaustegui DA; Tuero I; Mohanram V; Musich T; Pegu P; Valentin A; Sui Y; Rosati M; Bear J; Venzon DJ; Kulkarni V; Alicea C; Pilkington GR; Liyanage NP; Demberg T; Gordon SN; Wang Y; Hogg AE; Frey B; Patterson LJ; DiPasquale J; Montefiori DC; Sardesai NY; Reed SG; Berzofsky JA; Franchini G; Felber BK; Pavlakis GN; Robert-Guroff M
    Clin Immunol; 2014 Aug; 153(2):308-22. PubMed ID: 24907411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Mucosal Adenovirus Prime/Systemic Envelope Boost Vaccine Regimen Elicits Responses in Cervicovaginal and Alveolar Macrophages of Rhesus Macaques Associated With Delayed SIV Acquisition and B Cell Help.
    Hunegnaw R; Helmold Hait S; Enyindah-Asonye G; Rahman MA; Ko EJ; Hogge CJ; Hoang T; Robert-Guroff M
    Front Immunol; 2020; 11():571804. PubMed ID: 33117363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge.
    Kwa S; Lai L; Gangadhara S; Siddiqui M; Pillai VB; Labranche C; Yu T; Moss B; Montefiori DC; Robinson HL; Kozlowski PA; Amara RR
    J Virol; 2014 Sep; 88(17):9579-89. PubMed ID: 24920805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rational basis for mucosal vaccination against HIV infection.
    Lehner T; Bergmeier L; Wang Y; Tao L; Mitchell E
    Immunol Rev; 1999 Aug; 170():183-96. PubMed ID: 10566151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prime/Boost Vaccine Regimen Alters the Rectal Microbiome and Impacts Immune Responses and Viremia Control Post-Simian Immunodeficiency Virus Infection in Male and Female Rhesus Macaques.
    Musich T; Thovarai V; Venzon DJ; Mohanram V; Tuero I; Miller-Novak LK; Helmold Hait S; Rahman MA; Hunegnaw R; Huiting E; Yuan W; O'hUigin C; Hoang T; Sui Y; LaBranche C; Montefiori D; Bear J; Rosati M; Bissa M; Berzofsky JA; Pavlakis GN; Felber BK; Franchini G; Robert-Guroff M
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early events in sexual transmission of HIV and SIV and opportunities for interventions.
    Haase AT
    Annu Rev Med; 2011; 62():127-39. PubMed ID: 21054171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replicating Adenovirus-SIV Immunization of Rhesus Macaques Induces Mucosal Dendritic Cell Activation and Function Leading to Rectal Immune Responses.
    Ko EJ; Helmold Hait S; Enyindah-Asonye G; Rahman MA; Hoang T; Robert-Guroff M
    Front Immunol; 2019; 10():779. PubMed ID: 31031768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIV and HIV prophylaxis.
    Ada GL; Müllbacher A
    Nat Med; 1996 Oct; 2(10):1054-5. PubMed ID: 8837592
    [No Abstract]   [Full Text] [Related]  

  • 11. Innate and adaptive mucosal immunity in protection against HIV infection.
    Lehner T
    Vaccine; 2003 Jun; 21 Suppl 2():S68-76. PubMed ID: 12763686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses.
    Abel K; Pahar B; Van Rompay KK; Fritts L; Sin C; Schmidt K; Colón R; McChesney M; Marthas ML
    J Virol; 2006 Jul; 80(13):6357-67. PubMed ID: 16775324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
    Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
    J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge.
    Bogers WM; Davis D; Baak I; Kan E; Hofman S; Sun Y; Mortier D; Lian Y; Oostermeijer H; Fagrouch Z; Dubbes R; van der Maas M; Mooij P; Koopman G; Verschoor E; Langedijk JP; Zhao J; Brocca-Cofano E; Robert-Guroff M; Srivastava I; Barnett S; Heeney JL
    Virology; 2008 Dec; 382(2):217-25. PubMed ID: 18947849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV.
    Weaver EA; Nehete PN; Nehete BP; Yang G; Buchl SJ; Hanley PW; Palmer D; Montefiori DC; Ferrari G; Ng P; Sastry KJ; Barry MA
    PLoS One; 2013; 8(7):e67574. PubMed ID: 23844034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoprofiling Correlates of Protection Against SHIV Infection in Adjuvanted HIV-1 Pox-Protein Vaccinated Rhesus Macaques.
    Lu P; Guerin DJ; Lin S; Chaudhury S; Ackerman ME; Bolton DL; Wallqvist A
    Front Immunol; 2021; 12():625030. PubMed ID: 34046030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
    Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
    J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques.
    Petitdemange C; Kasturi SP; Kozlowski PA; Nabi R; Quarnstrom CF; Reddy PBJ; Derdeyn CA; Spicer LM; Patel P; Legere T; Kovalenkov YO; Labranche CC; Villinger F; Tomai M; Vasilakos J; Haynes B; Kang CY; Gibbs JS; Yewdell JW; Barouch D; Wrammert J; Montefiori D; Hunter E; Amara RR; Masopust D; Pulendran B
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques.
    Sexton A; De Rose R; Reece JC; Alcantara S; Loh L; Moffat JM; Laurie K; Hurt A; Doherty PC; Turner SJ; Kent SJ; Stambas J
    J Virol; 2009 Aug; 83(15):7619-28. PubMed ID: 19439474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective immune responses against HIV/SIV by live attenuated vaccine in non-human primate models].
    Fukazawa Y
    Uirusu; 2012; 62(2):167-74. PubMed ID: 24153227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.